Company: CLX
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0000021076-25-000023
Chunk: 107

Company: CLOROX CO /DE/
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 2
Chunk 107
---
$1,814 (8)%$5,116 $5,190 (1)%

Three months ended March 31, 2025Percentage change versus the year-ago periodReported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & Divestitures (1)Foreign Exchange ImpactPrice/Mix/ Other (2)Organic Sales Growth / (Decrease) (Non-GAAP) (3)Organic Volume (4)Health and Wellness3 %7 %— %— %(4)%3 %7 %Household(11)(9)— — (2)(11)(9)Lifestyle(3)(2)— — (1)(3)(2)International (4)(15)(15)(14)(3)3 2 1 Total Company (4)(5)(8)%(7)%(5)%(1)%— %(2)%— %Nine months ended March 31, 2025Percentage change versus the year-ago periodReported (GAAP) Net Sales Growth / (Decrease)Reported VolumeAcquisitions & Divestitures (1)Foreign Exchange ImpactPrice/Mix/Other (2)Organic Sales Growth / (Decrease) (Non-GAAP) (3)Organic Volume (4)Health and Wellness7 %9 %— %— %(2)%7 %9 %Household1 2 — — (1)1 2 Lifestyle2 3 — — (1)2 3 International (4)(11)(11)(14)(3)3 6 6 Total Company (4)(5)(1)%(1)%(5)%— %— %4 %5 %

(1)The divestiture impact is calculated as net sales from the Argentina and Better Health VMS businesses after the respective sale dates in the three and nine month year-ago periods.

(2)This represents the net impact on net sales growth / (decrease) from pricing actions, mix, trade promotion spending, mix from acquisitions and divestitures and other factors. In the three months ended March 31, 2025, the impact from divestiture mix was 2% for both International and Total Company. In the nine months ended March 31, 2025, the impact from divestiture mix was 3% and